Endoüroloji Bülteni

Yazarlar: Arif AYDIN, Gökhan ECER, Muzaffer Tansel KILINÇ, Mehmet BALASAR, Nurullah ALTINKAYA, Hakan Hakkı TAŞKAPU, Mehmet Giray SÖNMEZ

Konular:Üroloji ve Nefroloji

Anahtar Kelimeler:Penile fracture,Erectile dysfunction,Penile hematoma

Özet: Objective: Prostate cancer is one of the most common malignities in males. It is separated into low, intermediate and high risk groups to determine the most suitable treatment regimen. Treatment of average risk prostate cancer is controversial due to the heterogeneity of the patients included in this classification. In recent years, these patients were separated into two groups as 'Favourable' in which a better prognosis is expected and as 'Unfavourable' in which a worse prognosis is expected. Active surveillance, radical prostatectomy and radiotherapy are the available options for intermediate risk prostate cancer. Material and Method: We retrospectively evaluated 36 patients in intermediate risk group who had radical prostatectomy in our clinic due to prostate cancer between 2016 and 2020. We separated the patients into two groups as favourable and unfavourable based on risk factors. We statistically compared preoperative prostate biopsy and radical prostatectomy pathology results, postop 3 and 6 month control PSA results, surgical border positivity ratios and the differences between clinical and pathological stages of the patients using SPSS program. Results: Positive core number, post op. 3rd and 6th month PSA values, positive core count, surgical border positivity, post radical protatectomy upstaging ratio were detected higher in unfavourable group. These differences were statistically insignificant. Positive core percentage was statistically significantly higher in unfavourable group (P<0.001). Conclusion: Intermediate risk prostate cancer is a heterogeneous disease group. Treatment regimens should be selected by considering factors such as age, additional disease and patient expectation.

---